Industry News & Announcements

    Industry News & Announcements

    Biogen Inc. (Nasdaq: BIIB) announced the European Commission (EC) has authorized SKYCLARYS® (omaveloxolone) for the treatment of Friedreich’s ataxia (FA) in adults and adolescents aged 16 years and older. SKYCLARYS is the first treatment approved within the European Union for this rare, genetic, progressive neurodegenerative disease.

    Biogen
    Powered By GrowthZone

    Get Updates
    from LSPA

    Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry,  and so much more!

    LifeSciencesPA_logo

    Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University.  Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.

    Reach Out to us

    411 Swedeland Road
    Suite 23-1080
    King of Prussia, PA 19406